2024 SPEAKERS
Ajibade Adesina, Director, PV Process Excellence and Learning Strategy, Bristol-Myers Squibb
Celine Adessi, Global Head, Clinical Sciences, Early Development Oncology, Roche
Ana Sofia Afonso, Director, Pharmacoepidemiology, Global Patient Safety, Eli Lilly
Amit Aggarwal, Executive Director, Medical Affairs & Strategic Partnerships, ABPI
Omar Aimer, Executive Member of ISoP and NASoP President, International Society of Pharmacovigilance (ISoP)
Alison Allen, Director, Global Pharmacovigilance (PV) Quality Assurance, Alnylam Pharmaceuticals
Ibrahim Altamawy, Medical Affairs & Compliance Regional Head (MENA), SAJA Pharmaceuticals
Anand Ananthakrishnan, Senior Director, Drug Safety and Pharmacovigilance, Blueprint Medicines
Kate Anteyi, Director, Global Safety Physician, Moderna Therapeutics
Wasim Anwar, Vice President, Deputy QPPV, Novo Nordisk A/S
Esther Aparicio, Manager, Pharmacovigilance, UBC
Ludovic Apoux, Director, Safety Signal & Risk Management, Haleon
Julia Appelskog, Senior Director, EU QPPV, Global Vaccine Safety, Novavax
Felix Arellano, Global Head of Pharmacovigilance and Drug Safety, Roche
Ercem Atillasoy, Chief Regulatory and Safety Officer, Jazz Pharmaceuticals
Mina G Awad, Pharmacovigilance Senior Manager and QPPV, Middle East, Kyowa Kirin International
Tea Babic, Director, Head of PV Audits and Inspections, Deputy Head PV Compliance, Teva Pharmaceuticals
Jamal Baig, Director, Pharmacovigilance, Multi Country Safety Head, Sanofi
Nicole Baker, CEO, biologit
Amina Baljic, Senior Director, Head, PV Operations and PV Excellence, Grunenthal
Marta Bałuka, Manager, Global Case Management, PV Operations, Moderna
Marianne Banoub, Regional Head of PV and QA, NewBridge Pharmaceutical
Maja Barac, Chief Executive Officer & EU QPPV, Pharmavigil
Alexandru Barbarosie, EU/UK QPPV, Global Safety Lead, Amryt Pharma
Erika Barbarosie, Associate Director, Compliance, Gilead Sciences
Tiago Barca Ramos, Global Lead, Clinical & Drug Safety, Compliance & Operations, Swiss QPPV, Bavarian Nordic
Matteo Barion, Digital Innovation & Technologies Unit Head, QPPV Office, Chiesi Farmaceutici SpA
Judy Barretto, Senior Director, Virology TA, Patient Safety, Gilead
Eniko Barta Kondas, Head, Global PV Operations, Gedeon Richter PLC
Sylvie Bartus, Senior Director, Clinical Safety Global, Clinical Affairs, Surgical Structural Heart, Edwards Lifesciences
Erica Bavol, Senior Director, Head of Safety Operations, Compliance and Systems, Corcept
Begum Benli Peker, Director, Head of Patient Safety Netherlands & EU Hub Lead, Bristol Myers Squibb
Ricarda Berg, Head of Drug Safety Germany & Local QPPV, GSK
Majken Berghuis, Director, Pharmacovigilance, International Operations, Novo nordisk
Fabrice Besle, Director, PV Database & Analytic Reporting, Ipsen
Mayank Bhandari, Co-Founder, Head, Global Consulting, Ultragenic Research & Technologies LLC
Fatima Bhayat, Independent PV Expert
Kapil Bhutada, Senior Director, Quality and Compliance, Inozyme Pharma
Olga Błaszczyk, Manager, Global Case Management, PV Operations, Moderna
Laura Paola Boga, Senior Director, Head of Global Pharmacovigilance, UK & EU QPPV, Dompé Farmaceutici SpA
Chris Bone, Director, Safety and Benefit Risk, Biogen
Emma Boulton, Director, Local Safety Operations, Mundipharma
Ronald Boumans, Independent Medical Devices Expert, EU Medical Devices Expert
Barbara Bovy, Director, Head, Auditing and Compliance EarlyDevSol, Innovation & Data, UCB
Alex Brenchat, Vice President, Local Pharmacovigilance Services, PharmaLex
Siva Kumar Buddha, Director, Pharmacovigilance, Head of Signals and Risk Management, Indegene Inc.
Sean Burke, Senior Director, Regional Lead, International Pharmacovigilance, MSD
Gloria Bustos Busto, Senior Director, Head of Pharmacovigilance, EMEA & APAC / Global Patient Safety, Baxter Healthcare
Mattia Calissano, Director, Head of Pharmacovigilance, Orchard Therapeutics
Isabella Caramuta, Deputy QPPV, Shionogi BV
Patrick Caubel, Chief Safety Officer, Pfizer
Akhilesh Chamediya, Global Medical Director, Patient Safety Lead, AstraZeneca & Alexion
Mijal Chavda, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin International
David Chonzi, Independent Pharma Physician, Independent PV Expert
Mugdha Chopra, Co-Founder and Director, AWINSA Life Sciences
Maria Chrzanowska, Associate Director, Clinical Trial Safety Scientist, AstraZeneca
Irina Maria Ciubotaru, Vice President, Head of Global Drug Safety and Pharmacovigilance, EU & UK QPPV, ITM Isotope Technologies Munich SE
Mircea Ciuca, Executive Director, TA Lead, Global Pharmacovigilance, Organon
Jan Cleerbout, Deputy QPPV, Johnson & Johnson Innovative Medicine
Marco Colombati, PV Operations Manager, ITALFARMACO S.P.A.
Lynne Comiskey, Divestment Coordination Lead, Sanofi
Galina Cordero, Head of Pharmacovigilance Department, QPPV, JSC Farmak
Elena Cucu, Deputy EU QPPV, AbbVie
Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics
Mark Daniels, Director, Safety Physician, Jazz Pharmaceuticals
Margherita D'Antuono, EU-UK QPPV, Piramal Critical Care
Michelle Motta Dardeno, Vice President, Head, Global Patient Safety, Aurinia
Magda Daudin, Director, Head of PV Operations and Compliance, Idorsia
Abiola David, Senior Director, Global Process Owner, ICSR Management, PV Operations, Gsk
Elena Davison, Executive Director, Global Pharmacovigilance Informatics, Sunovion Pharmaceuticals
Anthonius de Boer, Chairman, CBG-MEB Medicines Evaluation Board
Jolanda De Bruijne, Senior Director, Head of PV Compliance, Teva Pharmaceuticals
Fabio De Gregorio, Vice President, Head Of Drug Safety Europe, Shionogi BV
Peter De Veene, Associate Vice President, Global QPPV, MSD
Frédérique Delannois, Executive Director, Safety Evaluation & Risk Management Head, Global Safety, Gsk
Sunita Dhar, Executive Medical Group Director, Clinical Safety, Genentech
Daniela Di Cosmo, Senior Safety Advisor, Global Safety, Ferring Pharmaceuticals
Elisabetta Di Martino, Director, GCP, GVP & GLP, Quality Assurance, Orchard Therapeutics
Francesca Dickins, Associate Director, Medicines Quality Organization, Eli Lilly
Shaantanu Donde, Senior Medical Director, Head of Portfolio Management Team, Clinical Development & Medical Affairs, Viatris
Updesh Dosanjh, Practice Lead Safety Technology, IQVIA
Joan D'souza, Independent PV Expert
Melanie Dullemond, PV Compliance Head, Medical and PV Quality, Sanofi
Marjan Dzeparoski, RA and PV Manager, Bionika Pharmaceuticals
Ekaterina Edle von Dall'Armi, Deputy Local QPPV & Senior Medical Advisor Patient Safety, GSK
Phillip Eichorn, Global Head of Drug Safety, Chiesi
Dineke Eikelboom, Associate Director, Medical Safety, Pharmacovigilance, Astellas Pharma
James Eldridge, Director, Global Safety Surveillance, Y-mAbs
Maha Lakshmi Elluri, Global Safety Director, EEA/UK QPPV, Indivior Pharmaceuticals
Sebastian Fischer, Regulatory Strategy Principal, TUV SUD Product Service GmbH
John Fitzpatrick, Senior Pharmacovigilance Manager, ProPharma
Veronica Fjellstrom, Global Head, Pharmacovigilance and Patient Safety, Oncopeptides AB
Marie Flanagan, Director, Offering Management, IQVIA
Garry Flounders, Global Pharmacovigilance Operations Lead, Biosimilars, Biogen
Suzanne Foncin, Senior Director, Head of Safety Analysis and Writing, UCB
Sarah Freestone, Vice President, Head of Pharmacovigilance and Device Safety, UCB Pharma
Antonella Fretta, Senior Director, Aggregate Reporting Team Lead, Pfizer
Ilana Frishman, Senior Director, Pharmacovigilance & Drug Safety, Compugen
Tsambika Fuchs, Team Lead PV Intelligence and Performance Management, Merck Healthcare KGaA
Giovanni Furlan, Director, Worldwide Safety Site Lead, Pfizer
Stewart Geary, Global Safety Officer, Eisai
Serban Ghiorghiu, Chief Safety Officer, AstraZeneca
Ilaria Grisoni, Executive Director, Head of EU & International Pharmacovigilance, QPPV Office and EEA QPPV, Jazz Pharmaceuticals
Katarzyna Gruchala, Director, PV Operations Global Submissions, Moderna
Uwe Gudat, Chief Medical Officer, Biocon Biologics
Sibel Guerler, Senior Director, Head of Innovation, Partnerships and Process Optimisation, WorldWide Patient Safety, Bristol Myers Squibb
Israel Gutierrez, Chief Medical Officer, TLR Therapeutics
Diane Halle, Senior Manager, Pharmacovigilance Quality Assurance, Alnylam Pharmaceuticals
Camilla Hammerum, Vice President, Head of GPS TA Oncology, Ipsen
Joanna Han, Independent PV Expert
Pat Harding, Senior Advisor, Medicines Quality Organisation, Eli Lilly and Company
John Hart, Director, EEA & UK QPPV, Samsung Bioepis NL B.V
Fabian Heisig, Senior Vice President, Head Global Drug Safety & QPPV, Grunenthal
Cristina Hentea, Director, Safety Surveillance and Risk Management, Viatris
Peter Hjelmstrom, Director and Chief Executive Officer, Uppsala Monitoring Centre
Juri Hodisch, Head, Drug Safety, QPPV, AOP Health
Myrto Ioannidi, Director, Pharmacovigilance, UBC
Javed Iqbal, Senior Director Pharmacovigilance, Elanco
Maximilian Jacobs, Head of Vendor Management, Pharmacovigilance, Bayer AG
Nathalie Joffre, Global Vigilance Director, EU QPPV, Biocodex, Inc.
Conny Johansson, Alliance Management Lead, Roche
Philip Jones, Senior Director, Disease Area Cluster Lead, Inflammation & Immunology, Pfizer
Rafael Josupeit, EEA QPPV, Procter & Gamble
Justin Joubert, Senior Director, Acquisitions, PV Agreements & Contract Liason, Gsk
Juhaeri Juhaeri, Vice President & Global Head, Epidemiology and Benefit-Risk, Sanofi
Avinash Kakade, Senior Vice President, Global Head of Pharmacovigilance, Dr. Reddy's Laboratories
Mette Stie Kallesøe, Head of Pharmacovigilance, QPPV, Hansa Biopharma
Achilleas Kalogirou, Lead, Office of Safety Operations, AbbVie
ELENA KELLER, Director, PV, RA, Quality and Medical Operations, Local QPPV, Ipsen Pharma GmbH
Ranjana Khanna, Global Director, GVP, QA, R&D Quality, BeiGene
Ben Kitchens, Associate Director, Medical Devices, Diagnostics Lead, Otsuka Pharmaceutical Companies (U.S.)
Kristin Knalstad, Director, Risk Management, Patient Safety, Astrazeneca
Peter Kohut, Head of Pharmacovigilance, Alvotech
Anna Kończak, EU QPPV, Polpharma
Mohammed Ali Kotal, Global Head, Medical Safety, Sandoz International GmbH
Smruti Kothari, Associate Director, PV QA, Jazz Pharmaceuticals
Monika Kowalska, Director, Global Case Management, Moderna
Marcin Kruk, Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East, Pfizer
Leith Kwaan, QPPV, National Bioproducts Institute NPC
Graeme Ladds, CEO & Owner, PharSafer
Wally Landsberg, Vice President, Global Head Medical Safety, Kyowa Kirin, Inc.
Belkis Lanza, Drug Safety Coordinator, QBD Group
Finn Larsen, Head, Technology and Data Management, Sandoz Patient Safety
Stella Lee, Independent PV Expert
Jost Leemhuis, Safety Science Partner and Global Business Lead, Roche
Claudia Lehmann, Vice President, Head, Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International
Fabio Lievano, Vice President, Safety Science, AbbVie
Luiz Lima, Vice President, Head of Neuroscience, Global Patient Safety, Ipsen
Rita Lobatto, Vice President, Pharmacovigilance & QPPV, Pharming Group
Emanuel Lohrmann, Director, PV Therapeutic Area Lead, Cardio Renal, Otsuka Pharmaceuticals
Karsten Lollike, Corporate Vice President, QPPV, Novo nordisk
Rajakumari Long, Deputy Director, Integrated Development, Global Health, Bill and Melinda Gates Foundation
Claire Longman, Expert Pharmacovigilance Inspector, MHRA
Dominika Łukasz, Associate Director, Clinical Trial Safety Scientist, AstraZeneca
Mariette M Boerstoel, Senior Vice President, Worldwide Patient Safety Officer, Bristol Myers Squibb
Asif Mahmood, Vice President, Medical Safety & Pharmacovigilance, AskBio
Ewa Malinowska, Associate Director, Global Pharmacovigilance Case Management, MSD
Valentina Mancini, Senior Director, Pharmacovigilance, EU & UK QPPV, Shionogi & TransCelerate
Monika Manske, Associate Director, Lead Quality Management and Deputy EEA QPPV, Viatris
Marcin Marciniak, Senior Director, Global Safety and PV Expert WHC, Gedeon Richter Switzerland
Jessica Mårlind Würtele, Director, Patient Safety Excellence, Astrazeneca
Miriam Marotti, Senior Medical Director, Patient Safety Oncology, AstraZeneca
Paul Maruff, Chief Innovation Officer, Cogstate
Robert Massouh, Head, Risk Management and Benefit-Risk Evaluation, GSK
Asa Mattsson, Senior Director, Patient Safety Risk Management, Process & Implementation, Astrazeneca
Jorgen Matz, Global Head, Pharmacovigilance & Clinical Quality, INSUD PHARMA
Richard Mayer, Senior Principal Engineer, Head of Medical Safety R&D, Johnson and Johnson
Kristine Mcgraw, Director, Safety Systems and Quality, Erasca, Inc.
Fabio Miceli, EU QPPV, Norgine
Sanjeev Miglani, Founder and Director, AWINSA Life Sciences
Jose Miyar Olaiz, Senior Medical Director, Patient Safety Physician, Astrazeneca
Andrew Moore, Director, PV Operations and Compliance, Takeda
Marianne Mounir, Senior Global System Auditor, Bayer
Céline Muffang, Associate Director, Medical Safety & Pharmacovigilance, AskBio
Sutirtha Mukhopadhyay, Senior Associate Director, Senior Patient Safety Physician, Boehringer Ingelheim
Barry Mulchrone, Head of Safety Science & Strategy Lifecycle Safety, IQVIA
Raghunandan Murthy, Director, Business Transformation and PV Consulting, Sophos IT Services
Milind Nadgouda, Director, Operations, RiverArk Limited
Jaylaxmi Nalawade, Director, Pharmacovigilance and REMS, Lupin
Yvonne Nanciu, Country Head, Pharmacovigilance, Deputy EU QPPV, Bayer
Dominic Nguyen-Van-Tam, Senior Pharmacovigilance Inspector, MHRA
Thomas Nirnberger, Chief Executive Officer, Biofi
Minhaj Obeidullah, Head, Compliance and Risk Management, Novartis
Kieran O'Donnell, Director, Independent PV Expert
Adeniyi Olagunju, Senior Lecturer, University of Liverpool
Attila Oláh, Vice President, Head, Global Patient Safety, EU-QPPV, Gedeon Richter PLC
Ann-Marie Orange, Chief Information Officer, ArisGlobal
Tom Organ, Safety Science Director, Neuroscience TA, Global Patient Safety, Ipsen
Emma Outram, Group Head, Safety Data Acquisition, Roche Products Ltd
Devi padmanaban, Executive Director, Neurocrine Biosciences
Karine Palin, Eu2P Programme Manager, University of Bordeaux
Shaloo Pandhi, Global Head, Patient Safety, Sandoz
Krupa Patel, Senior Safety Scientist, Global Patient Safety, Ipsen
George P. Patrinos, Professor, Department of Pharmacy & Adjunct Professor, Department of Genetics and Genomics, University of Patras & United Arab Emirates University
Meenal Patwardhan, Vice President, Medical Safety Evaluation & Safety Data Sciences, AbbVie
Anna Pelnikevich, Director, Head of Benefit-Risk Management, Merck
Teodora Perger, Senior Medical Director, Global Safety Physician, AstraZeneca
Iveta Petrova, Director, Product Management, Digital Science
Claudia Pierleoni-Nielsen, Director, Global Safety Surveillance, LEO Pharma
Emmanuelle Pinès, Head of Safety Policy & Process Oversight, QPPV Office, Janssen
Iwona Piotrowska-Potapczyk, Associate Director, Global Pharmacovigilance Case Management, MSD
Elena Prokofyeva, Head of Drug Safety Unit, DG Post, FAMHP - Federal Agency for Medicines and Health Products in Belgium
Donald Puccio, Senior Director, Team Leader Oncology, Aggregate Reports, Pfizer
Marta Pujol, Senior Director, Patient Safety, Astrazeneca
Humaira Qureshi, President, Qinecsa Solutions
Oana Rad, Senior Safety Scientist, B Braun
Nibedita Rath, Scientific Director, Open Source Pharma Foundation
Tjark Reblin, Senior Vice President, Global Head of Patient Safety, Ipsen
Ranga Reddy, Head of Drug Safety Technologies, Former CSL Vifor
Maria Jose Reneses, Director, Deputy EU QPPV and Head of PSMF, Takeda
Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Nayanika Rivankar, Signal Management Strategy Lead, Merck Group
Nathan Rivers, Associate Director, Medical Safety, Oncology, Jazz Pharmaceuticals
Kathy Roberts, Vice President, Global Phamacovigilance, Incyte Corp.
Hadir Rostom, Independent PV Expert - Lecturer, Modern Sciences And Arts University
Maha Saad, Associate Vice President, Pharmacovigilance & REMS, Braeburn Pharmaceuticals
Zina Sadeq, Director, Regional PV and Alliance Management, Deputy UK QPPV, AMICUS THERAPEUTICS
Kishore Saha, Chief Specialist, Lundbeck
Balaji Sainath Malla, Head of Pharmacovigilance, QPPV- EU & UK, Dr. Reddy's Laboratories Inc
Myriam Salem, Pharmacovigilance Manager, Health Canada
Teresa Saragoça, Technical Director and Head of Regulatory Affairs, Italfarmaco PT
Gemma Sayers, Senior Director, Head, Global Development Quality Management, Regeneron Pharmaceuticals
Yvonne Schäfer, Head of Patient Safety & Pharmacovigilance Systems Business Solutions, Boehringer Ingelheim International
Claudia Schaffer, Senior Director, Head of Case and Vendor Management, Merck
Rudi Scheerlinck, Safety Strategy Lead, Merck Healthcare Oncology
Olaf Schickling, Senior Director, Head of QPPV Office, BeiGene Germany GmbH
Reinhold Schilling, Head of Global Pharmacovigilance, EU QPPV, Wörwag Pharma
Nadine Schreiber, Head, Global Pharmacovigilance, Medac GmbH
Uwe Schühly, Head of Drug Safety and Pharmacovigilance, Santhera Pharmaceuticals
Carrie Scott, Head, Global Pharmacovigilance Compliance and Policy, AbbVie
Maurizio Sessa, Associate Professor, Pharmacovigilance and Pharmacoepidemiology, University of Copenhagen
Nikesh Shah, Vice President and Global Head, Drug Safety and Pharmacovigilance, Indegene
Riti Shah, Senior Medical Director, Pharmacovigilance, Chiesi
john solomon, Head of Pharmacovigilance, UK & Ireland, Sanofi
Martin Sournac, Manager, Global Pharmacovigilance operations, Incyte
Anna Stahl, Deputy QPPV, BeiGene
Vivien Stettner, Director, International PSEQ Strategy & Sights, AbbVie
Tim Stockley, Senior Director, Compliance and Inspection Readiness, Patient Safety, AstraZeneca
Milos Stojkovic, Safety Process Director, Roche
Ariane Stollenwerk, Director, Head of Central Europe & Asian Int. Markets, International PhV, UCB Pharma
Johanna Strandell, Director, Patient Safety, Camurus AB
Karthick Sukumaran, Director, Technology Enablement, Intelligent Safety Automation, Roche Products Ltd
Jutta Syha, Independent PV Expert, Independent PV Expert
Azwi Takalani, Program Lead, HIV Vaccine Trials Network South Africa
Stéphanie Tcherny-Lessenot, Global Head, Benefit-Risk Evaluation, Sanofi
Tarak Thakker, Director, Head of Safety Systems and Analytics, BeiGene
Phil Tregunno, Deputy Director, Patient Safety Monitoring, Medicines & Healthcare products Regulatory Agency
Marco Tuccori, Pharmacovigilance Manager, Coordinator & Co-Chair, University Hospital of Pisa, Tuscan Regional Centre of Pharmacovigilance & ISoP Scientific Board
Alina Ioana Tudor, Global Head, Medical Evaluation and ICSR Review, Kyowa Kirin
Raj Vaghela, Chief Executive Officer, PubHive Ltd.
Martijn van de Leur, Chief Operating Officer PV/RA/MI, Biomapas
Vivienne van de Walle, Medical Director, P.T. and R
Willemijn Van Der Spuij, Executive Director, International Patient Safety, Bristol-Myers Squibb
Lionel Van Holle, Founder, OpenSourcePV
Bert Van Leeuwen, Senior Director, Deputy QPPV, Astellas Pharma Europe BV
Mary Lynne van Poelgeest-Pomfret, President, World Federation for Incontinence and Pelvic Problems (WFIPP)
Valerie Vandevoorde, Executive Director, Global Pharmacovigilance Quality Head, MSD
Sarah Vaughan, Head of Vigilance Operations, MHRA
Deepa Venkataraman, Vice President, Head of Global Drug Safety and Pharmacovigilance, Corcept Therapeutics
Sriram Venkateswaran, Safety Data Science Director, Hoffmann la Roche Ltd
Jin Vermaat, Vice President, Head of PV Affiliate Relations, Takeda
Michael von Forstner, Head of Safety Science, Global Pharmacovigilance and Patient Safety, Sobi (Swedish Orphan Biovitrum)
Heike von Treichel, Senior Director, Deputy EU QPPV, Head of PV QMS and QPPV Office, Merck
Ivana Vranic, Director, Safety Risk Lead, Inflammation & Immunology, Pfizer
Aman Wasan, Chief Executive Officer, ArisGlobal LLC
Rebecca Webb, Senior Director, Safety, Vigilance and Medical Affairs QA, AbbVie
Heinz Weidenthaler, Global Principal Safety Physician, EU QPPV, Bavarian Nordic
James Whitehead, Senior Director, Devices and Digital Safety, Astra Zeneca
Mark Widdowson, Senior Manager, Digital Capabilities, WorldWide Patient Safety, Bristol Myers Squibb
Tina Wirstrom, Director, EU QPPV Office, Takeda
Rui Yang, Senior Medical Safety Director, Team Lead, Pharmacovigilance, Drug Safety, Genmab
Barbara Yousif, PV & QA Manager, OnePharmaMedics
Dilara Yuksel Gunbay, Associate Director, Patient Safety, AHoPS, Gilead Sciences
Martine Zimmermann, Senior Vice President, Head of Global Regulatory Affairs, Ipsen
Monika Zych, Director, Pharmacovigilance, Baxter
Get Involved At
World Drug Safety Congress
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events